Imaging of Specific Activation of Photodynamic Molecular Beacons in Breast Cancer Vertebral Metastases

2011 ◽  
Vol 22 (6) ◽  
pp. 1021-1030 ◽  
Author(s):  
Tracy W. Liu ◽  
Margarete K. Akens ◽  
Juan Chen ◽  
Lisa Wise-Milestone ◽  
Brian C. Wilson ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Molecular Beacons ◽  
Vertebral Metastases

MR Imaging with Histopathological Correlation in Vertebral Metastases of Breast Cancer

1992 ◽  
Vol 33 (3) ◽  
pp. 213-220 ◽  
Author(s):  
M. Petren-Mallmin ◽  
B. Nordstrom ◽  
I. Andreasson ◽  
R. Nyman ◽  
H. Jonsson ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Vertebral Metastases ◽  
Histopathological Correlation

Does parasternal irradiation reduce thoracic vertebral metastases in breast cancer?

1988 ◽  
Vol 14 (3) ◽  
pp. 565-569 ◽  
Author(s):  
Laval Grimard ◽  
Libni Eapen ◽  
Rebecca McDermot ◽  
Paul Genest ◽  
Rama Nair
Keyword(s):  
Breast Cancer ◽  
Vertebral Metastases

scholarly journals Percutaneous Vertebroplasty in Vertebral Metastases from Breast Cancer: Interest in Terms of Pain Relief and Quality of Life

2014 ◽  
Vol 20 (5) ◽  
pp. 591-602 ◽  
Author(s):  
Héctor Manuel Barragán-Campos ◽  
Anne-Laurence Le Faou ◽  
Michèle Rose ◽  
Alain Livartowski ◽  
Marianne Doz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Pain Relief ◽  
Percutaneous Vertebroplasty ◽  
Morbidity Rate ◽  
Safe Procedure ◽  
Vertebral Metastases ◽  
Ct Guided

Percutaneous vertebroplasty (PV) is a therapeutic option in patients with vertebral metastases (VM). However its efficacy in pain relief, improvement in quality of life and safety in patients with VM from breast cancer has not been reported. We present a longitudinal retrospective study of 31 consecutively treated female patients with VM from breast cancer where 88 vertebrae were treated in 44 sessions of PV, in which osteolytic, osteoblastic and mixed lesions were recorded. The visual analogue pain scale (VAS) was used to evaluate pain pre-PV, at one, three, six and 12 months post-PV. The Eastern Cooperative Group (ECOG) performance status scale was used at the same time intervals to measure quality of life: 90.3% pain relief was identified with a VAS reduction from 5.7 ± 2.0 pre-PV to 2.9 ± 2.2 post-PV at one-month follow-up (p<0.001) and 0.6 ± 1.0 at 12-month follow-up (p<0.001). In our series 48.4% of patients were classified as having an ECOG grade 0 and 1 pre-PV, which increased to 80.8% at the 12-month follow-up. While 22.6% of the patients were classified at ECOG grades 3 and 4 pre-PV, this improved to 0% at 12 months follow-up. The morbidity rate for this procedure was 12.9% immediately and only 3.2% at 30 days post-PV with all complications being resolved medically or with CT-guided infiltration. PV is a safe procedure with a high efficacy in pain relief, and improvement of quality of life in patients with diverse types of VM from breast cancer.

scholarly journals Surgical Results of Vertebral Metastases of Breast Cancer

2004 ◽  
Vol 53 (4) ◽  
pp. 777-783
Author(s):  
Takayoshi Rokkaku ◽  
Katsuo Arakaki ◽  
Kunihiko Uehara ◽  
Tsugukazu Toma ◽  
Hirokazu Nohara ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Vertebral Metastases ◽  
Surgical Results

scholarly journals Bioimaging of multiple piRNAs in a single breast cancer cell using molecular beacons

MedChemComm ◽  
2017 ◽  
Vol 8 (12) ◽  
pp. 2228-2232 ◽  
Author(s):  
Yong Keun Park ◽  
Woon Yong Jung ◽  
Min Geun Park ◽  
Sung Kyu Song ◽  
Yong Seung Lee ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Molecular Beacons

Simultaneous bioimaging of piR-36026 and piR-36743 using molecular beacons successfully visualized 4 different subtypes of breast cancer.

Sign in / Sign up

Export Citation Format

Share Document